## TER: Teradyne, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 1.0% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (34% of avg), momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($185.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Teradyne Stock (NASDAQ: TER) News: Shares Hover Near $199 as U.S. Markets Close for the Weekend, Analysts Spotlight AI Test Demand**
- Source: ts2.tech | 20251227T220054 | Somewhat-Bullish | Relevance: 100%
- Teradyne, Inc. (NASDAQ: TER) stock is consolidating below the $200 level as U.S. markets close for the weekend, influenced by accelerating demand related to artificial intelligence infrastructure and ongoing analyst commentary. Shares last traded around $198.90, with a slight gain in extended trading. Analysts, notably Goldman Sachs and Stifel, have recently upgraded Teradyne, citing strong AI test demand and potential growth into 2026.

**2. Teradyne's UltraFLEXplus Gains Traction: A Sign for More Upside?**
- Source: TradingView â€” Track All Markets | 20251224T170824 | Bullish | Relevance: 100%
- Teradyne's UltraFLEXplus system is seeing increased demand, particularly benefiting its Semiconductor Test business, which saw revenues rise significantly in Q3 2025. The company recently launched UltraPHY 224G to expand its high-speed test capabilities, designed to meet the growing needs of AI-driven applications and data centers. Despite strong competition from companies like Advantest and Cohu, Teradyne anticipates solid top-line growth, projecting Q4 2025 revenues between $920 million and $1 billion, and its stock has shown impressive performance.

**3. Teradyne, Inc. $TER Position Decreased by Kempner Capital Management Inc.**
- Source: MarketBeat | 20251227T132442 | Somewhat-Bullish | Relevance: 100%
- Kempner Capital Management Inc. significantly reduced its stake in Teradyne, Inc. by 46.2% in the third quarter, selling 21,192 shares and ending with 24,710 shares valued at $3.40 million. Despite this, Teradyne recently reported strong Q3 earnings, beating analyst estimates with EPS of $0.85 and revenue of $769.2 million, and its stock is trading near a one-year high. Institutional ownership remains very high at 99.77%, and analysts generally rate the stock as a "Moderate Buy" with an average target price of $185.75.

**4. SWS Partners Buys Shares of 15,866 Teradyne, Inc. $TER**
- Source: MarketBeat | 20251227T115818 | Bullish | Relevance: 100%
- SWS Partners initiated a new position in Teradyne, Inc. (NASDAQ:TER) by purchasing 15,866 shares worth approximately $2.18 million in the third quarter, increasing institutional ownership to 99.77%. Despite insider selling by CEO Gregory Smith, analysts maintain a largely positive outlook with a "Moderate Buy" consensus rating and an average price target of $185.75, with some firms like Goldman Sachs upgrading their target to $230. The company reported strong financial results for the last quarter, beating revenue and EPS estimates, and announced a quarterly dividend.

**5. Texas Permanent School Fund Corp Sells 12,303 Shares of Teradyne, Inc. $TER**
- Source: MarketBeat | 20251225T103025 | Somewhat-Bullish | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Teradyne, Inc. by 53.2% in Q2, selling 12,303 shares and retaining 10,830 shares valued at approximately $974,000. Additionally, CEO Gregory Stephen Smith sold 1,108 shares worth over $223,000, contributing to a total of 3,324 insider shares sold in the last 90 days. Despite insider selling, Teradyne recently surpassed quarterly earnings estimates and maintains a "Moderate Buy" consensus analyst rating with an average target price of $185.75.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Goldman Sachs | $230 | $148 | +55% |
| 2025-12-02 | Stifel | $225 | $162 | +39% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Goldman Sachs | up | Buy |
| 2025-12-02 | Stifel | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 7 ($1.13M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+2.1%)
- Blackrock Inc.: 8.4% (-7.2%)
- JPMORGAN CHASE & CO: 5.4% (+126.5%)
- State Street Corpora: 4.0% (+0.3%)
- Ameriprise Financial: 3.0% (+6.8%)

### Key Risks

1. High beta (1.85) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_20 falling (-2.0% 5d) with bearish MACD, trend may be turning.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 38.7x attractive for 46% earnings growth. Quality metrics strong (margin 16%). Balance sheet: low leverage (D/E 0.46). Revenue growth strong at 23% YoY. Analyst sentiment positive (2 raises, avg +47%). Insider selling cluster ($1.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $31.6B |
| Beta | 1.85 |
| 52W Range | $65.77 - $205.00 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 38.7 |
| Current P/E | 56.5 |
| YoY Growth | 45.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.0% to 1.0% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.87), momentum weakening. Volume at 34% of 20MA suggests lack of conviction. OFD pattern: -DLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.04% (CS: 66) | Neutral |
| RSI_14 | 60.8 | Neutral |
| MACD Histogram | -0.87 | Bearish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 1.126x | Above |
| vs SMA200 | 1.695x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $198.90
- **Stop Loss:** $185.00 (7.0% risk)
- **Target:** $212.80 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $15,713.10
- **Portfolio %:** 15.71%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-28 (Est: $1.36)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.79 | $0.85 | +7.4% |
| 2025Q2 | $0.54 | $0.57 | +4.9% |
| 2025Q1 | $0.62 | $0.75 | +21.7% |
| 2024Q4 | $0.91 | $0.95 | +4.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*